Testified at a hearing before the U.S. House of Representatives' Committee on Ways and Means as a neutral ERISA pundit regarding Appropriateness of 401(k) Fees
This event has already occurred.
Related Insights
The Dietary Supplement Innovation Act—What Stakeholders Should Know as the Legislation Moves Forward